Geneos Wealth Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
Geneos Wealth Management's EDIT Position: Q3 2024 in Review
Geneos Wealth Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 400 shares — an estimated $1.87K sold.
Geneos Wealth Management first reported a position in EDIT in Q4 2017 and held it in 26 quarters. The position peaked at $55K in Q2 2021. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.
- Geneos Wealth Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
- Geneos Wealth Management sold 400 Editas Medicine shares in Q3 2024, an estimated $1.87K.
- Geneos Wealth Management first reported a position in Editas Medicine in Q4 2017 and held it in 26 quarters.
- Geneos Wealth Management's Editas Medicine position peaked at $55K in Q2 2021.
- 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.
Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.